Sonomind
French tech company | Builders Republic
About
Medical device company developing a non-invasive brain-stimulation therapy that uses low-intensity focused ultrasound, delivered through a patient-specific acoustic lens, to precisely target deep brain regions and treat drug-resistant depression and other neuropsychiatric disorders — built on decades of academic ultrasound research.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series A
- Founded
- 2024
- City
- PARIS
- Region
- IDF
- Tracked rounds
- 2
- Amount raised
- 23 M€ raised since 2020
Funding rounds
- Series A — 2026
- Seed — 2025